Dai Kun purchased $1K of UXIN (indirect holdings)

Dai Kun (Chief Executive Officer) purchased 1,300 indirectly-held shares of Uxin Ltd (UXIN) at $0.93 on 2026-11-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Dai Kun
Published Nov 3, 2026, 2:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 2:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$UXIN
Bullish
medium confidence
Mentioned
$UXIN
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$UXINBullishLow
01

Why it matters

The disclosure provides incremental sentiment information but does not indicate a new corporate event, guidance change, or material capital action.

02

Market read

Traders may treat this as a minor positive sentiment datapoint, but it is unlikely to drive a sustained repricing without additional catalysts.

03

What to watch

For microcap/low-liquidity names, insider trades can be noisy; traders may need to corroborate with volume, spreads, and any concurrent company disclosures.

Relevance 2/10Novelty 2/10Timing: filed 2026-11-03, transaction dated 2026-11-02

Background

The article is an SEC Form 4 insider transaction disclosure for Uxin Ltd, reported by CEO Dai Kun.

Company-level read

Ticker impact

$UXINBullishMedium confidence
Context

SEC Form 4 shows CEO Dai Kun bought 1,300 shares of Uxin Ltd at $0.9307 on 2026-11-02 under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact, with any reaction more sentiment-driven than fundamental.

Evidence & confidence

The filing is a primary Form 4 disclosure, but the transaction size is modest and explicitly tied to a pre-arranged 10b5-1 plan, reducing interpretive edge.

Market effects

No clear sector read-through from a single small insider purchase.

None.

None.

Counterpoint

Because the purchase is under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity rather than a fresh bullish view.

Key entities

  • Uxin Ltd

    Subject of the Form 4 insider transaction disclosure.

  • Dai Kun

    CEO and director who executed an open-market purchase under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$UXINMedAI 8/10

Uxin (UXIN) Q2 2026 Earnings Call Transcript

Uxin (UXIN) reported Q2 2026 revenue of RMB 1.51B, up 75% YoY, with retail volume up 89% and wholesale volume up 88%. Gross margin turned negative at -0.7% due to inventory adjustments. Q3 guidance: 20,500-21,000 retail units, RMB 1.16B-1.19B revenue, and >6% gross margin. CEO plans $5M share purchase. Industry consolidation expected, with 50,000-60,000 dealerships forecast to exit by year-end.

$UXINMed

Uxin Q2 Loss Widens; Shares Up

Uxin Limited reported a wider net loss of RMB 183.33 million ($27.02 million) in Q2 2026, up from RMB 73.80 million a year ago, with total revenues increasing to RMB 1.151 billion ($169.66 million). The company forecasted Q3 revenue of RMB 1.16-1.19 billion and a gross profit margin above 6.0%. Shares rose 13.30% to $1.2350 on Nasdaq.

$UXINMed

Uxin Ltd (UXIN): Financial results for Q2 2026

Uxin Ltd (UXIN) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Uxin Reports Unaudited Financial Results for the Quarter Ended June 30, 2026 BEIJING, September 24, 2026 – Uxin Limited (“Uxin” or the “Company”) (Nasdaq: UXIN), China’s leading used car retailer, today announced its unaudited financial results for the quarter ended

$UXINMed

Why is Uxin stock surging today?

Uxin (UXIN) stock rose 6.42% in pre-market trading after reporting Q2 2026 revenue of RMB1,151.2 million, up 74.9% YoY. The company projected Q3 revenue of RMB1,160-1,190 million and a gross profit margin above 6.0%, reversing a prior -0.7% margin. Management attributed margin weakness to temporary market conditions. The rally occurred despite broader market declines, highlighting company-specific optimism.

$UXINMed

Uxin Q1 Earnings Call Highlights

Uxin (NASDAQ: UXIN) reported Q1 adjusted EBITDA loss of CNY 34.3 million, widening sequentially from CNY 27.2 million, which management attributed to Chinese New Year seasonality and higher ramp-up and staffing costs. Management cited auto-market weakness: first five months’ new vehicle sales down 20% YoY and April-May ICE sales down over 35% YoY, with used ICE prices falling 10%-15% in 1-2 months. Uxin said gross margin may face more pressure in Q2, but expects improvement in Q3 if ICE prices s